LMAT vs UDR · P/E 35, rev $136.9M vs P/E 26, rev $1.71B
LeMaitre Vascular Inc (LMAT) versus UDR Inc (UDR) — a side-by-side from cached financials, not a winner call.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
UDR Inc (UDR) is a reit - residential company listed on NYSE.
Latest reported LMAT revenue for 2026-06-30 was $136.9M. Net income was $32.7M. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Latest reported UDR revenue for 2025-12-31 was $1.71B. Net income was $377.7M. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
LMAT currently screens at market cap $2.16B and trailing P/E 34.8. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
Not investment advice. Open the LMAT and UDR stock pages for the full models.
Not investment advice.